InvestorQ : How were the quarterly profit numbers for Sun Pharma for the Sep-20 quarter?
Anamika Sodhani made post

How were the quarterly profit numbers for Sun Pharma for the Sep-20 quarter?

Answer
image
Angel dcosta answered.
4 weeks ago
Follow

Pharma companies have not had a good time for the last many quarters but finally it looks like the largest Indian pharma company, Sun Pharma, had a quarter to rejoice. Sun reported an improvement in operating performance as well as sustained reduction of debt.

India growth story was a major story for Sun Pharma in the midst of the pandemic. Among the key market segments of Sun Pharma, the Indian formulations market accounting for 30% of sales grew by 6% sequentially, month over month.

The Emerging Markets business accounting for 20% of the sales also managed to grow by 21% on a sequential basis while the US markets accounting for 30% was actually flat. During the quarter, Sun Pharma invested nearly Rs.613 crore on R&D which almost made up for 7.2% of the overall sales.

This puts Sun Pharma on par with global pharma majors on the front of R&D spending. The company also had an interesting story on debt reduction. It repaid debt to the tune of $300 million, reducing its debt / equity ratio from 0.18 to 0.13, making its balance sheet cleaner and healthier.

1 Views